top of page
Fluidx is redefining embolization with an easy-to-use and highly controllable ionic gel embolization platform, which will be used to treat a wide range of conditions including tumors, hemorrhage, and targeted neurovascular bleeds.
Consistent. Fast. Complete.
Fluidx presents topline results from the GPX IDE Pivotal Trial at SIR 2026
-
The prospective, multicenter, multinational study was designed to assess the safety and effectiveness of GPX for peripheral vascular embolization.
-
More than 40 investigators enrolled 114 patients at 18 sites across the United States, Canada, and New Zealand.
-
Results presented in Late Breaking presentation at SIR2026
Embolic Technologies
Peripheral distal embolic
Peripheral embolics for hemorrhage and other applications
Neurovascular distal embolic
Latest Press
Fluidx Medical’s GPX Embolic Device – durable liquid embolic
* Data on file. Fluidx Medical Technology, Inc.
The GPX Embolic Device, ULTRA Embolic Platform, and IMPASS Embolic Device are under development and do not have marketing clearance or approval in any market at this time.
bottom of page